Expectation of cutting down of medical bills by administering half-dose sitagliptin

Authors
Category Primary study
Registry of TrialsUMIN Clinical Trials Registry
Year 2017
INTERVENTION: Reduction of dose of sitagliptin or not. Standard dose of sitagliptin. CONDITION: Japanese patients with non‐insulin dependent diabetes PRIMARY OUTCOME: HbA1c SECONDARY OUTCOME: Bady weight,1.5AG,C‐peputide index INCLUSION CRITERIA: 1. Age 20 years<= 2. HbA1c <7.0% 3. eGFR 60mL/min/1.73m <= 4. Concomitant medicines is sitagliptin only or sitagliptin and metformin or sitagliptin and sulfonylurea or sitagliptin and metformin and sulfonylurea. 5. Under treatment with fixed diet and exercise. 6. Hb male 13.5‐17.6g/dL female 11.3‐15.2g/dL
Epistemonikos ID: 6f571a235b2a8407baec3ad1673cd86884c279e9
First added on: Jul 02, 2024